Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA-associated vasculitis overlap

被引:6
作者
Farah, Randa, I [1 ]
Abu Shahin, Nisreen [2 ]
Alawneh, Mohannad [3 ]
Adwan, Marwan [4 ]
机构
[1] Univ Jordan, Sch Med, Internal Med Dept, Nephrol Div, Amman, Jordan
[2] Univ Jordan, Sch Med, Dept Pathol & Microbiol & Forens Med, Amman, Jordan
[3] Univ Jordan, Sch Med, Internal Med Dept, Amman, Jordan
[4] Univ Jordan, Sch Med, Internal Med Dept, Rheumatol Div, Amman, Jordan
关键词
SLE; vasculitis; MPO-ANCA; overlap syndrome; NEPHRITIS; RITUXIMAB;
D O I
10.1177/0961203320920368
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) and ANCA-associated vasculitis (AAV) are different autoimmune diseases. While vasculitis can be seen in the SLE clinical course as a secondary phenomenon, and may indicate a severe disease, primary vasculitis such as AAV rarely occurs in association with SLE. We present a 44-year-old woman who presented with rapidly progressive glomerulonephritis which was histologically identified as a combination of crescentic and lupus nephritis in the presence of myeloperoxidase ANCA antibody. The frequency of this association is very rare. The clinical, histological and immunological features are different in SLE/AAV overlap syndrome and need different treatment options, which may include rituximab, to achieve complete recovery. Since SLE/AAV overlap can be serious at presentation, the physician must be aware of this syndrome.
引用
收藏
页码:983 / 986
页数:4
相关论文
共 10 条
[1]  
Changal KH, 2016, CASE REP RHEUMATOL, V2016, P4507247
[2]   Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis [J].
Clain, Jeremy M. ;
Cartin-Ceba, Rodrigo ;
Fervenza, Fernando C. ;
Specks, Ulrich .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2014, 6 (02) :58-74
[3]   Characteristics and Histological Types of Lupus Nephritis in a Jordanian Tertiary Medical Center [J].
Farah, Randa I. ;
Dannoun, Ebtesam ;
Abu Shahin, Nisreen ;
AlRyalat, Saif Aldeen .
BIOMED RESEARCH INTERNATIONAL, 2019, 2019
[4]   Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis [J].
Jarrot, Pierre-Andre ;
Chiche, Laurent ;
Hervier, Baptiste ;
Daniel, Laurent ;
Vuiblet, Vincent ;
Bardin, Nathalie ;
Bertin, Daniel ;
Terrier, Benjamin ;
Amoura, Zahir ;
Andres, Emmanuel ;
Rondeau, Eric ;
Hamidou, Mohamed ;
Pennaforte, Jean-Loup ;
Halfon, Philippe ;
Daugas, Eric ;
Dussol, Bertrand ;
Puechal, Xavier ;
Kaplanski, Gilles ;
Jourde-Chiche, Noemie .
MEDICINE, 2016, 95 (22)
[5]  
Lazarus B, 2016, Indian J Nephrol, V26, P86, DOI 10.4103/0971-4065.171225
[6]   Con: Cyclophosphamide for the treatment of lupus nephritis [J].
Mok, Chi Chiu .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (07) :1053-1057
[7]   Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity [J].
Nasr, Samih H. ;
D'Agati, Vivette D. ;
Park, Hye-Ran ;
Sterman, Paul L. ;
Goyzueta, Juan D. ;
Dressler, Robert M. ;
Hazlett, Shawn M. ;
Pursell, Robert N. ;
Caputo, Christopher ;
Markowitz, Glen S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03) :682-690
[8]   Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy [J].
Turner-Stokes, Tabitha ;
Wilson, Hannah R. ;
Morreale, Massimiliano ;
Nunes, Ana ;
Cairns, Tom ;
Cook, H. Terence ;
Pusey, Charles D. ;
Tarzi, Ruth M. ;
Lightstone, Liz .
KIDNEY INTERNATIONAL, 2017, 92 (05) :1223-1231
[9]   Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis [J].
Yu, Feng ;
Tan, Ying ;
Liu, Gang ;
Wang, Su-xia ;
Zou, Wan-zhong ;
Zhao, Ming-hui .
KIDNEY INTERNATIONAL, 2009, 76 (03) :307-317
[10]   Clinical efficacy and safety of rituximab in lupus nephritis [J].
Zhong, Zhiqing ;
Li, Hongyan ;
Zhong, Hongzhen ;
Zhou, Tianbiao .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :845-856